Insmed Inc. buy Guggenheim
Start price
07.02.25
/
50%
€78.00
Target price
07.02.26
€97.77
Performance (%)
58.97%
End price
08.02.26
€124.00
Summary
This prediction ended on 08.02.26 with a price of €124.00. The BUY prediction by Guggenheim for Insmed Inc. saw massive gains of 58.97%. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.078% | -3.078% | 3.898% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $95.00 to $101.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten